Cite
HARVARD Citation
Glintborg, B. et al. (n.d.). FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry. Annals of the rheumatic diseases. pp. 553-554. [Online].